Post Content Previous Post Mphasis shares fall 5% on reports of losing its third-largest client Next Post Piramal Pharma shares gain after Canada unit gets zero observations from USFDA with no action indicated Leave a ReplyCancel ReplyYour email address will not be published. Required fields are marked * Name * Email * Website Add Comment * Save my name, email and website in this browser for the next time I comment.Post Comment
